These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 14518585)

  • 1. Evaluation of patient knowledge regarding oral anticoagulants.
    Roche-Nagle G; Chambers F; Nanra J; Bouchier-Hayes D; Young S
    Ir Med J; 2003; 96(7):211-3. PubMed ID: 14518585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Audit of an anticoagulant clinic: doctor and patient knowledge.
    McCormack PM; Stinson JC; Hemeryck L; Feely J
    Ir Med J; 1997; 90(5):192-3. PubMed ID: 9345833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of an anticoagulant clinic.
    Colwell N; O'Neill T; Tyrrell J; Robinson K; Clarke R; Graham I
    Ir Med J; 1990 Sep; 83(3):94-7. PubMed ID: 2228544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing anticoagulation knowledge in patients new to warfarin therapy.
    Winans AR; Rudd KM; Triller D
    Ann Pharmacother; 2010; 44(7-8):1152-7. PubMed ID: 20571105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Self testing and self management of oral anticoagulants with warfarin].
    Nadav L; Schwartz J
    Harefuah; 2003 Sep; 142(8-9):621-3, 645, 644. PubMed ID: 14518167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of adherence, knowledge, and quality of life on anticoagulation control.
    Davis NJ; Billett HH; Cohen HW; Arnsten JH
    Ann Pharmacother; 2005 Apr; 39(4):632-6. PubMed ID: 15713790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO; Lal L; Brown EN; Braun UK
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective evaluation of a pharmacist-managed warfarin anticoagulation clinic.
    Garabedian-Ruffalo SM; Gray DR; Sax MJ; Ruffalo RL
    Am J Hosp Pharm; 1985 Feb; 42(2):304-8. PubMed ID: 3976675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New perspectives for anticoagulation in non-rheumatic atrial fibrillation: oral antithrombins].
    Scardi S; Giansante C
    Ital Heart J Suppl; 2004 Sep; 5(9):705-11. PubMed ID: 15568608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
    Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic.
    Abdelhafiz AH; Wheeldon NM
    Clin Ther; 2004 Sep; 26(9):1470-8. PubMed ID: 15531009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of thromboembolism with short-term interruption of warfarin therapy.
    Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
    Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.
    Garwood CL; Corbett TL
    Ann Pharmacother; 2008 Apr; 42(4):523-32. PubMed ID: 18334606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation therapy: patient management and evaluation of an outpatient clinic.
    Kornblit P; Senderoff J; Davis-Ericksen M; Zenk J
    Nurse Pract; 1990 Aug; 15(8):21-6, 29, 32. PubMed ID: 2398969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an instrument to determine patient knowledge: the oral anticoagulation knowledge test.
    Zeolla MM; Brodeur MR; Dominelli A; Haines ST; Allie ND
    Ann Pharmacother; 2006 Apr; 40(4):633-8. PubMed ID: 16551766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy Insight: management of urology patients taking long-term warfarin anticoagulation therapy.
    Daniels PR
    Nat Clin Pract Urol; 2005 Jul; 2(7):343-50. PubMed ID: 16474787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin prevalence, indications for use and haemorrhagic events.
    Ouirke W; Cahill M; Perera K; Sargent J; Conway J
    Ir Med J; 2007 Mar; 100(3):402-4. PubMed ID: 17491542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.